Megha A. Parikh, PhD, MS

For Medicare Advantage beneficiaries, high out-of-pocket medical costs are associated with lower odds of medication adherence.

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.